Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/26/24 → 7/1/29 |
Funding
- Fortrea, Inc. (Prot #GO44479 // Prot #GO44479)
- Genentech, Inc (Prot #GO44479 // Prot #GO44479)
Prot #GO44479: A Phase II, Open-label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients with Resected Pancreatic Ductal Adenocarcinoma
- Mulcahy, Mary Frances (PD/PI)
Project: Research project